VANGUARD GROUP INC - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 106 filers reported holding SURFACE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$2,008,155
+24.4%
2,309,2860.0%0.00%
Q1 2023$1,613,729
-14.8%
2,309,2860.0%0.00%
Q4 2022$1,893,614
-21.1%
2,309,286
+0.0%
0.00%
Q3 2022$2,401,000
-18.7%
2,308,470
+28.2%
0.00%
Q2 2022$2,953,000
-34.0%
1,800,380
+18.4%
0.00%
Q1 2022$4,471,000
-35.9%
1,521,003
+4.2%
0.00%
Q4 2021$6,978,000
-23.8%
1,459,905
+20.7%
0.00%
Q3 2021$9,154,000
+2.6%
1,209,221
+1.2%
0.00%
Q2 2021$8,918,000
+5.6%
1,195,432
+10.4%
0.00%
Q1 2021$8,442,000
-9.6%
1,082,422
+7.1%
0.00%
Q4 2020$9,336,000
+54.1%
1,010,502
+15.1%
0.00%
Q3 2020$6,057,000
+95.1%
877,876
+85.5%
0.00%
Q2 2020$3,104,000
+250.7%
473,1770.0%0.00%
Q1 2020$885,000
-0.7%
473,177
-0.1%
0.00%
Q4 2019$891,000
+32.2%
473,677
-0.2%
0.00%
Q3 2019$674,000
-59.5%
474,713
-19.5%
0.00%
Q2 2019$1,663,000
-43.9%
589,373
-5.1%
0.00%
Q1 2019$2,962,000
+269.8%
620,946
+228.9%
0.00%
Q4 2018$801,000
-83.3%
188,807
-57.0%
0.00%
Q3 2018$4,804,000
-3.1%
439,077
+44.5%
0.00%
Q2 2018$4,956,000303,8610.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates XI, LLC 2,945,453$27,216,0004.31%
Atlas Venture Associates IX, LLC 2,945,453$27,216,0004.31%
ACUTA CAPITAL PARTNERS, LLC 999,500$9,235,0002.51%
COMMODORE CAPITAL LP 467,796$4,322,0002.35%
Ghost Tree Capital, LLC 1,000,000$9,240,0002.06%
VR Adviser, LLC 1,442,895$13,332,0001.96%
SILVERARC CAPITAL MANAGEMENT, LLC 130,000$1,201,0000.70%
Parkman Healthcare Partners LLC 175,792$1,624,0000.42%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 26,732$247,0000.39%
One68 Global Capital, LLC 15,071$139,0000.28%
View complete list of SURFACE ONCOLOGY INC shareholders